Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists

Bioorg Med Chem. 2006 Apr 15;14(8):2725-46. doi: 10.1016/j.bmc.2005.11.058. Epub 2005 Dec 27.

Abstract

A series of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives were synthesized and evaluated for their activity as VLA-4 antagonists. Of 22 compounds synthesized, 19 compounds showed potent activity with low nanomolar IC50 values. In addition, the representative compounds 11o and 11p with a hydroxy group in the pyrrolidine ring showed moderate plasma clearance in rats (11o, 30 ml/min/kg and 11p, 21 ml/min/kg) and in dogs (11o, 12 ml/min/kg and 11p, 9 ml/min/kg).

MeSH terms

  • Acetates / chemical synthesis*
  • Acetates / pharmacokinetics
  • Acetates / pharmacology
  • Animals
  • Dogs
  • Integrin alpha4beta1 / antagonists & inhibitors*
  • Magnetic Resonance Spectroscopy
  • Male
  • Piperazines / chemical synthesis*
  • Piperazines / pharmacokinetics
  • Piperazines / pharmacology
  • Piperidines / chemical synthesis*
  • Piperidines / pharmacokinetics
  • Piperidines / pharmacology
  • Proline / analogs & derivatives*
  • Proline / chemical synthesis
  • Proline / pharmacokinetics
  • Proline / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Spectrometry, Mass, Fast Atom Bombardment

Substances

  • Acetates
  • Integrin alpha4beta1
  • Piperazines
  • Piperidines
  • prolyl-1-piperazinylacetic acid
  • prolyl-4-piperidinylacetic acid
  • Proline